| Phase 4 |
| NCT07561892 |
Study of the Effectiveness and Safety of Daunorubicin /Idarubicin ± Silibinin in Treating… |
Acute Myeloid Leukemia |
Recruiting |
2026-05-01 |
| NCT06785584 |
Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable… |
ALK-positive Advanced NSCLC |
Not Yet Recruiting |
2025-01-21 |
| Phase 3 |
| NCT06559696 |
Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant… |
Breast Cancer |
Recruiting |
2024-09-19 |
| NCT06441110 |
Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and… |
Urinary Bladder Neoplasms |
Recruiting |
2024-06-04 |
| NCT04009265 |
Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for… |
Esophageal Squamous Cell Carcinoma |
Recruiting |
2021-11-12 |
| NCT07788001 |
A Non-inferiority Study of Indocyanine Green-guided Sentinel Lymph Node Mapping Versus… |
Esophageal Cancer |
Not Yet Recruiting |
2026-08-26 |
| NCT07541755 |
PD-1 Inhibitors +Venetoclax+CAG Regimens in R/R T-ALL |
Acute T Lymphoblastic Leukemia (T-ALL) |
Active, Not Recruiting |
2026-04-21 |
| NCT07406815 |
The Value of Near-Infrared Fluorescence Imaging in the Protection of the Recurrent… |
Esophageal Cancer |
Not Yet Recruiting |
2026-02-12 |
| NCT07303231 |
The Value of Indocyanine Green-guided Near-infrared Fluorescence Technology in Tracing… |
Esophageal Cancer |
Not Yet Recruiting |
2025-12-24 |
| NCT05970900 |
Preoperative Imatinib Mesylate Combined With Rectal-sparing Surgery in Patients With… |
Gastrointestinal Stromal Tumor of Rectum |
Not Yet Recruiting |
2023-08-01 |
| Phase 2 |
| NCT07296705 |
Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation… |
Muscle Invasive Bladder Cancer (MIBC) |
Recruiting |
2025-12-22 |
| NCT06601309 |
Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC |
Esophageal Squamous Cell Carcinoma |
Recruiting |
2025-09-15 |
| NCT05704166 |
PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following… |
Acute Lung Injury |
Recruiting |
2025-08-08 |
| NCT06791070 |
A Study of RC48-ADC Combined With JS001 for Advanced Extramammary Paget Disease of the… |
Paget Disease, Extramammary |
Recruiting |
2025-01-24 |
| NCT06510660 |
Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for… |
Esophageal Squamous Cell Carcinoma |
Recruiting |
2024-09-19 |
| NCT05292742 |
Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With… |
Breast Cancer |
Recruiting |
2022-03-23 |
| NCT06816966 |
Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for… |
Small-cell Lung Cancer |
Enrolling by Invitation |
2025-02-10 |
| NCT06630871 |
A Clinical Trial Evaluating the Efficacy and Safety of Disitamab Vedotin Plus… |
NMIBC |
Not Yet Recruiting |
2024-10-10 |
| Phase 1/2 |
| NCT07679243 |
A Clinical Study on the Safety and Efficacy of Wide-Band Ultrasound Combined With… |
Keloid |
Not Yet Recruiting |
2026-07-01 |
| NCT05176002 |
Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma. |
Esophageal Neoplasm |
Active, Not Recruiting |
2025-11-19 |
| Phase 1 |
| NCT07551037 |
Efficacy and Safety of Autologous Peptide-induced Active Immunity in AML Maintenance… |
Acute Myeloid Leukemia |
Recruiting |
2026-05-01 |
| Early Phase 1 |
| NCT07665619 |
Clinical Efficacy of Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Combined… |
Radiation Cystitis |
Not Yet Recruiting |
2026-07-08 |
| NCT07198516 |
The Improvement Effect of Henggliejin on Fatty Liver in Type 2 Diabetes Patients With… |
NAFLD |
Not Yet Recruiting |
2025-09-30 |
| Not applicable |
| NCT07722091 |
Intraperitoneal Dexamethasone Spraying on Vagal Nerve-Rich Areas for Prevention of… |
Hoarseness |
Recruiting |
2026-09-23 |
| NCT05984628 |
Umbilical Cord Stem Cells for Skin Grafts in Donor Site Wounds |
Skin Wound |
Recruiting |
2026-09-03 |